Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.22 and traded as high as $0.22. Acerus Pharmaceuticals shares last traded at $0.22, with a volume of 0 shares changing hands.
Acerus Pharmaceuticals Stock Performance
The company has a quick ratio of 0.90, a current ratio of 1.35 and a debt-to-equity ratio of 0.64. The firm’s 50 day moving average is $0.22 and its two-hundred day moving average is $0.22. The stock has a market cap of $56.90 million, a price-to-earnings ratio of -2.75 and a beta of 2.60.
Acerus Pharmaceuticals Company Profile
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.
Featured Articles
- Five stocks we like better than Acerus Pharmaceuticals
- What Is WallStreetBets and What Stocks Are They Targeting?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
